Hepatocyte growth factor activator inhibitor type 1 (HAI-1) suppresses tumor growth and metastasis of pancreatic adenocarcinoma cells

被引：0
|
作者：
Ye, Jing-Jia [1 ]
Kawaguchi, Makiko [2 ]
Haruyama, Yukihiro [2 ]
Kanemaru, Ai [2 ]
Fukushima, Tsuyoshi [2 ]
Kataoka, Hiroaki [2 ]
机构：
[1] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China
[2] Miyazaki Univ, Miyazaki, Japan
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/1538-7445.TIM2013-B24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B24
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma
    Sakugawa C.
    Haruyama Y.
    Tanaka H.
    Fukushima T.
    Kawaguchi M.
    Kataoka H.
    [J]. BMC Research Notes, 10 (1)
  • [2] Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo
    Miyata, S
    Uchinokura, S
    Fukushima, T
    Hamasuna, R
    Itoh, H
    Akiyama, Y
    Nakano, S
    Wakisaka, S
    Kataoka, H
    [J]. CANCER LETTERS, 2005, 227 (01) : 83 - 93
  • [3] Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells
    Kohama, Kazuyo
    Kawaguchi, Makiko
    Fukushima, Tsuyoshi
    Lin, Chen-Yong
    Kataoka, Hiroaki
    [J]. HUMAN CELL, 2012, 25 (04): : 100 - 110
  • [4] Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells
    Kazuyo Kohama
    Makiko Kawaguchi
    Tsuyoshi Fukushima
    Chen-Yong Lin
    Hiroaki Kataoka
    [J]. Human Cell, 2012, 25 : 100 - 110
  • [5] Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for the integrity of intestinal epithelium
    Kawaguchi, Makiko
    Fukushima, Tsuyoshi
    Takeda, Naoki
    Hoshiko, Shinri
    Yorita, Kenji
    Kohama, Kazuyo
    Orikawa, Hiroshi
    Baba, Takashi
    Kataoka, Hiroaki
    [J]. FASEB JOURNAL, 2010, 24
  • [6] Expression of Hepatocyte Growth Factor Activator Inhibitor Type-1 (HAI-1) in Prostate Cancer
    Yasuda, Kenji
    Komiya, Akira
    Watanabe, Akihiko
    Morii, Akihiro
    Oya, Takeshi
    Nagakawa, Osamu
    Fujiuchi, Yasuyoshi
    Fuse, Hideki
    [J]. ANTICANCER RESEARCH, 2013, 33 (02) : 575 - 581
  • [7] Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta
    Tanaka, H
    Nagaike, K
    Takeda, N
    Itoh, H
    Kohama, K
    Fukushima, T
    Miyata, S
    Uchiyama, S
    Uchinokura, S
    Shimomura, T
    Miyazawa, K
    Kitamura, N
    Yamada, G
    Kataoka, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (13) : 5687 - 5698
  • [8] Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front
    Nagaike, K
    Kohama, K
    Uchiyama, S
    Tanaka, H
    Chijiiwa, K
    Itoh, H
    Kataoka, H
    [J]. CANCER SCIENCE, 2004, 95 (09): : 728 - 735
  • [9] In vivo expression of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in preeclamptic term human placenta
    Ishikawa, G
    Mori, M
    Isozaki, T
    Kataoka, H
    Takeshita, T
    Takizawa, T
    [J]. PLACENTA, 2005, 26 (8-9) : A53 - A53
  • [10] Serum hepatocyte growth factor activator inhibitor type I (HAI-1) and type 2 (HAI-2) in prostate cancer
    Nagakawa, O
    Yamagishi, T
    Akashi, T
    Nagaike, K
    Fuse, H
    [J]. PROSTATE, 2006, 66 (05): : 447 - 452
12345